Sleep EEG power spectra, insomnia, and chronic use of benzodiazepines.

STUDY OBJECTIVES The present study examined the sleep microstructure in relation to insomnia and chronic use of benzodiazepines in older adults. PARTICIPANTS The participants were 46 older adults, aged 55 or older (mean age = 62.9), who were divided into three groups: insomnia sufferers using BZ chronically (n = 15), drug-free insomnia sufferers (n = 15), and self-defined good sleepers (n = 16). DESIGN Participants completed 3 consecutive nights of polysomnography in the laboratory. Spectral analyses were carried on the second night of sleep recordings. Stages 2, 3, and 4 of the first 4 cycles of the second night were retained for the analysis. RESULTS Results showed no significant differences between drug-free insomnia sufferers and good sleepers. However, benzodiazepine users exhibited significantly less delta and theta activity over the night than did good sleepers. When compared to drug-free insomnia sufferers, benzodiazepine users had less delta and theta activity within cycle 2 only. Regarding high-frequency bands, benzodiazepine users had more beta 1 activity within cycle 3 than did good sleepers and more than both drug-free insomnia sufferers and good sleepers within cycle 4. CONCLUSIONS The findings show that spectral analysis is an efficient tool to detect and quantify the effects of benzodiazepine use on sleep structure, particularly with older adults, a group for whom macrostructure sleep alterations due to physiologic aging are hard to distinguish from sleep changes induced by insomnia and the use of hypnotic drugs. In addition, these results raise important questions about the effects and indications of prolonged use of benzodiazepine medications in older adults with insomnia complaints.

[1]  R. Daroff,et al.  The International Classification of Sleep Disorders , 1991, Neurology.

[2]  L. Johnson,et al.  Sleep spindle and delta changes during chronic use of a short-acting and a long-acting benzodiazepine hypnotic. , 1983, Electroencephalography and clinical neurophysiology.

[3]  P. Schweitzer,et al.  Ten-year trends in the pharmacological treatment of insomnia. , 1999, Sleep.

[4]  M. Bonnet,et al.  Do increases in beta EEG activity uniquely reflect insomnia? A commentary on "Beta EEG activity and insomnia" (M. L. Perlis et al.). , 2001, Sleep medicine reviews.

[5]  Daniel Aeschbach,et al.  Dynamics of Slow-Wave Activity and Spindle Frequency Activity in the Human Sleep EEG: Effect of Midazolam and Zopiclone , 1994, Neuropsychopharmacology.

[6]  E. Wolpert A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. , 1969 .

[7]  D. Giles,et al.  Beta EEG activity and insomnia. , 2001, Sleep medicine reviews.

[8]  K. Morgan,et al.  Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home , 1988, British medical journal.

[9]  T. Sejnowski,et al.  Thalamocortical oscillations in the sleeping and aroused brain. , 1993, Science.

[10]  C. Morin,et al.  Validation of the Insomnia Severity Index as an outcome measure for insomnia research. , 2001, Sleep medicine.

[11]  D. Giles,et al.  Beta/Gamma EEG activity in patients with primary and secondary insomnia and good sleeper controls. , 2001, Sleep.

[12]  Daniel J Buysse,et al.  Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. , 1997, JAMA.

[13]  T H Monk,et al.  The effects of age and gender on sleep EEG power spectral density in the middle years of life (ages 20-60 years old). , 2001, Psychophysiology.

[14]  A. Rechtschaffen,et al.  A manual of standardized terminology, technique and scoring system for sleep stages of human subjects , 1968 .

[15]  Charles M. Morin,et al.  Insomnia: Psychological Assessment and Management , 1993 .

[16]  D Lehmann,et al.  Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. , 1985, Human neurobiology.

[17]  C. Morin,et al.  Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. , 2004, The American journal of psychiatry.

[18]  M. First,et al.  Structured clinical interview for DSM-IV axis II personality disorders : SCID-II , 1997 .

[19]  C. Morin,et al.  Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. , 1999, JAMA.

[20]  R. Freedman,et al.  EEG power spectra in sleep-onset insomnia. , 1986, Electroencephalography and clinical neurophysiology.

[21]  J. Gaillard,et al.  Spectral characteristics of sleep EEG in chronic insomnia , 1998, The European journal of neuroscience.

[22]  C. Morin,et al.  Effects of chronic insomnia and use of benzodiazepines on daytime performance in older adults. , 2000, The journals of gerontology. Series B, Psychological sciences and social sciences.

[23]  E. Uhlenhuth,et al.  Insomnia and its treatment. Prevalence and correlates. , 1985, Archives of general psychiatry.

[24]  R. Bootzin,et al.  Psychophysiological insomnia: the behavioural model and a neurocognitive perspective , 1997, Journal of sleep research.

[25]  Charles M. Morin,et al.  Insomnia in adults , 2001, Current treatment options in neurology.

[26]  M. Terzano,et al.  Polysomnographic effects of hypnotic drugs , 1996, Psychopharmacology.

[27]  W. Mendelson Effects of flurazepam and zolpidem on the perception of sleep in insomniacs. , 1995, Sleep.

[28]  R D Ogilvie,et al.  Electrophysiological changes during the sleep onset period of psychophysiological insomniacs, psychiatric insomniacs, and normal sleepers. , 1995, Sleep.